News

Video

ASCRS Live: The safety of office-based cataract surgeries

Lance Kugler, MD, recapped his presentation and findings on the safety of office-based cataract surgery with the Ophthalmology Times© team at the ASCRS annual meeting in San Diego.

Lance Kugler, MD, recapped his presentation and findings on the safety of office-based cataract surgery with the Ophthalmology Times© team at the ASCRS annual meeting in San Diego.

Video transcript

Editor’s note: Transcript lightly edited for clarity.

Lance Kugler, MD:

I'm Lance Kugler. I'm here at ASCRS 2023 presenting a deeper look at complication rates in office space surgery centers. This has been a really hot topic for the past couple of years because of the rapid expansion of office space cataract surgery in the United States. and one of the top questions that patients ask is, is it safe? And so we looked that. In this particular study is 18,000 eyes in the study, looking at complication rates at centers across the United States. And, what we found was the complication rates were the same better than published, accepted complication rates, cataract surgery in seasoned hospitals.

The other thing that comes up a lot about office space surgeries centers is the concept that, a lot of people think that we're making the, that the sicker patients aren't being done there. And so, we looked at, in this paper, we looked at how many of these patients have comordidity, and we actually found that 62% of patients that we looked at had comorbidity, yet they were included in that same safety view. So, the conclusions of the study were that cataract surgery in office space setting is as safe or safer at your hospital.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
CIME 2025: Neda Shamie, MD, on expanding options in pharmacological presbyopia management
At CIME 2025, Neda Shamie, MD, answers questions about Demodex blepharitis
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
© 2025 MJH Life Sciences

All rights reserved.